India accounts for one-fourth of the world’s estimated 10.4 million new TB cases per year and nearly a third of the 1.7 million annual TB deaths. Although extrapulmonary TB accounts for 15-20% of the pulmonary TB, for a country like India, these numbers are quite significant. Most common presentation of neurotuberculosis in the Indian subcontinent is tuberculous meningitis (TBM). Early and rapid diagnosis is crucial for successful disease management as neurological sequelae in 20-25% is due to delay in diagnosis. Most of the existing TB tests like real-time PCR is beneficial but requires expensive equipment and expertise, limiting its use to highly sophisticated facilities.
Moreover, other molecular diagnostic tests like polymerase chain reaction (PCR) need costly equipment, while this modified test only uses a simple temperature-regulated water bath. This technique, in comparison to PCR, needs minimal training and can even be carried out by any literate person with simple training and instructions on how to conduct the test. Compared to the existing molecular tests, this tool takes 90 minutes to diagnose TB and it takes 6-7 hours for a diagnosis by using the PCR test techniques.
How does the technique work? It needs patients’ sample from where the DNA is extracted. To detect the presence of the TB DNA in this sample, some reagents are added and for an hour the tubes are placed in a hot water tub. When a dye is added to the tubes, colour changes to yellow and this confirms the presence of TB DNA in the sample.
“So, all it needs is a water bath which may or even be a battery-operated tub. The cost is less than Rs 100, while the PCR test costs Rs 500-600 and takes 6-7 hours for a confirmed diagnosis,” said Prof Sharma.
“We do smear test, culture and do a couple of molecular tests. However, as TB meningitis is an emergency and needs rapid and early diagnostics, this test is handy,” she added. Developing this modification took 4-5 work years and is ongoing. “The work is at the stage of evaluation and has been tested on patients. We have evaluated on various samples of more than 500 patients suffering with ocular (eye) TB, TB of the joints and TB meningitis etc,” said Prof Sharma.
................................ Advertisement ................................
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as an Editor-in-Chief for the Speciality Medical Dialogues section. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc.
Before Joining Medical Dialogues, he has served at important positions in the medical industry in India including as the Hony. Secretary of the Delhi Medical Association as well as the chairman of Anti-Quackery Committee in Delhi and worked with other Medical Councils in India. Email: email@example.com. Contact no. 011-43720751
To know about our editorial team click here